Scilex Holding (SCLX) Net Shares Issued and Repurchased (2020 - 2026)
Scilex Holding (SCLX) posted Net Shares Issued and Repurchased of $10000.0 for Q1 2026, up 1145.33% on a QoQ basis from $803.0 in Q4 2025, and up 66.67% year-over-year from $6000.0 in Q1 2025.
Analysis
Scilex Holding (SCLX) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends
Scilex Holding has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $10000.0 in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased rose 66.67% year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was $10000.0, a 66.67% increase from a year earlier, with the FY2025 full-year figure at $803.0, down 82.21% from the prior year.
- Net Shares Issued and Repurchased was $10000.0 for Q1 2026 at Scilex Holding, up from $803.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $1.8 million in Q4 2022, with the low at $228.0 in Q1 2024.
- Average Net Shares Issued and Repurchased over 5 years is $235122.0, with a median of $8000.0 recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased tumbled 99.04% in 2023, then surged 2531.58% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $1.8 million in 2022, then sank by 99.04% to $17610.0 in 2023, then slumped by 74.36% to $4515.0 in 2024, then slumped by 82.21% to $803.0 in 2025, then surged by 1145.33% to $10000.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $10000.0 (Q1 2026), $803.0 (Q4 2025), and $6000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Scilex Holding | 38.06 Mn | -76.90 Mn | 3.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 803.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 4,515.00 |
| Mar 31, 2024 | 228.00 |
| Dec 31, 2023 | 17,610.00 |
| Mar 31, 2023 | 14,820.00 |
| Dec 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 1.78 Mn |
| Dec 31, 2020 | 4.17 Mn |